lapatinib has been researched along with ly2090314 in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (ly2090314) | Trials (ly2090314) | Recent Studies (post-2010) (ly2090314) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 9 | 1 | 7 |
Protein | Taxonomy | lapatinib (IC50) | ly2090314 (IC50) |
---|---|---|---|
Protein kinase C beta type | Homo sapiens (human) | 0.42 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 1.8 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 2.8 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0013 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.001 | |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 6.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
1 other study(ies) available for lapatinib and ly2090314
Article | Year |
---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |